Gene · 3881
Papers1,648
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
161 to 180 of 1,648
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Tackling the Future Pandemics: Broad-Spectrum Antiviral Agents (BSAAs) Based on A-Type Proanthocyanidins. | Molecules | 2022 | 36500445 | PubTator, text mining | PubMed |
| Genetic characterization and pathogenicity of a Eurasian avian-like H1N1 swine influenza reassortant virus. | Virol J | 2022 | 36461007 | PubTator, text mining | PubMed |
| Real-time chirality transfer monitoring from statistically random to discrete homochiral nanotubes. | Nat Commun | 2022 | 36450720 | PubTator, text mining | PubMed |
| Reflections on the battle against COVID-19: The effects of emotional design factors on the communication of audio-visual art. | Front Psychol | 2022 | 36420378 | PubTator, text mining | PubMed |
| Retrospective immunogenicity analysis of seasonal flu H3N2 vaccines recommended in the past ten years using immunized animal sera. | EBioMedicine | 2022 | 36403423 | PubTator, text mining | PubMed |
| Keratin-mediated hair growth and its underlying biological mechanism. | Commun Biol | 2022 | 36402892 | PubTator, text mining | PubMed |
| Neoantigen-specific TCR-T cell-based immunotherapy for acute myeloid leukemia. | Exp Hematol Oncol | 2022 | 36384590 | PubTator, text mining | PubMed |
| Structure-Activity Studies of 1H-Imidazo[4,5-c]quinolin-4-amine Derivatives as A3 Adenosine Receptor Positive Allosteric Modulators. | J Med Chem | 2022 | 36367749 | PubTator, text mining | PubMed |
| Antiviral Potential of Natural Resources against Influenza Virus Infections. | Viruses | 2022 | 36366550 | PubTator, text mining | PubMed |
| Evolutionary Dynamics of Whole-Genome Influenza A/H3N2 Viruses Isolated in Myanmar from 2015 to 2019. | Viruses | 2022 | 36366512 | PubTator, text mining | PubMed |
| Respiratory illness virus infections with special emphasis on COVID-19. | Eur J Med Res | 2022 | 36348452 | PubTator, text mining | PubMed |
| Heat acclimation does not negatively affect salivary immunoglobulin-A and self-reported illness symptoms and wellness in recreational athletes. | Temperature (Austin) | 2022 | 36339091 | PubTator, text mining | PubMed |
| FOXA1 repression drives lineage plasticity and immune heterogeneity in bladder cancers with squamous differentiation. | Nat Commun | 2022 | 36323682 | PubTator, text mining | PubMed |
| A cell free biomembrane platform for multimodal study of influenza virus hemagglutinin and for evaluation of entry-inhibitors against hemagglutinin. | Front Mol Biosci | 2022 | 36310596 | PubTator, text mining | PubMed |
Serial Passaging of Seasonal H3N2 Influenza A/Singapore/G2-31.1/2014 Virus in MDCK-SIAT1 Cells and Primary Chick Embryo Cells Generates HA D457G Mutation and Other Variants in HA, NA, PB1, PB1-F2, and NS1. | Int J Mol Sci | 2022 | 36293269 | PubTator, text mining | PubMed |
| Is IIIG9 a New Protein with Exclusive Ciliary Function? Analysis of Its Potential Role in Cancer and Other Pathologies. | Cells | 2022 | 36291193 | PubTator, text mining | PubMed |
| Computational study on new natural compound inhibitors of Traf2 and Nck-interacting kinase (TNIK). | Aging (Albany NY) | 2022 | 36287174 | PubTator, text mining | PubMed |
| Towards Auditory Profile-Based Hearing-Aid Fittings: BEAR Rationale and Clinical Implementation. | Audiol Res | 2022 | 36285912 | PubTator, text mining | PubMed |
| Narrative review on century of respiratory pandemics from Spanish flu to COVID-19 and impact of nanotechnology on COVID-19 diagnosis and immune system boosting. | Virol J | 2022 | 36280866 | PubTator, text mining | PubMed |
| The pathogenesis of liver cancer and the therapeutic potential of bioactive substances. | Front Pharmacol | 2022 | 36278230 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/3881/papers?page=9